Thomson Medical Group
Market Cap
S$1.4b
Last Updated
2021/01/21 11:12 UTC
Data Sources
Company Financials
Executive Summary
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. More Details
Risk Analysis
Snowflake Analysis
Worrying balance sheet with weak fundamentals.
Similar Companies
Share Price & News
How has Thomson Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: A50 is not significantly more volatile than the rest of SG stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: A50's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
2.0%
A50
0.2%
SG Healthcare
5.0%
SG Market
1 Year Return
-16.1%
A50
-11.1%
SG Healthcare
23.7%
SG Market
Return vs Industry: A50 underperformed the SG Healthcare industry which returned -11.3% over the past year.
Return vs Market: A50 underperformed the SG Market which returned -9.9% over the past year.
Shareholder returns
| A50 | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.0% | 0.2% | 5.0% |
| 30 Day | 4.0% | 1.9% | 20.5% |
| 90 Day | 10.6% | 10.1% | 27.0% |
| 1 Year | -16.1%-16.1% | -9.2%-11.1% | 28.4%23.7% |
| 3 Year | n/a | -30.8%-36.0% | 57.9%42.3% |
| 5 Year | n/a | -19.5%-28.1% | 100.9%72.1% |
Long-Term Price Volatility Vs. Market
How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall St
Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year1 month ago | Simply Wall St
Is Thomson Medical Group (SGX:A50) Using Too Much Debt?4 months ago | Simply Wall St
Have Insiders Been Buying Thomson Medical Group Limited (SGX:A50) Shares This Year?Valuation
Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?
2.88x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: A50 (SGD0.05) is trading above our estimate of fair value (SGD0.01)
Significantly Below Fair Value: A50 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A50 is unprofitable, so we can't compare its PE Ratio to the SG Healthcare industry average.
PE vs Market: A50 is unprofitable, so we can't compare its PE Ratio to the SG market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A50's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A50 is overvalued based on its PB Ratio (2.9x) compared to the SG Healthcare industry average (2x).
Next Steps
Future Growth
How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
15.0%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Thomson Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Take a look at our analysis of A50’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Thomson Medical Group competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Thomson Medical Group performed over the past 5 years?
-68.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A50 is currently unprofitable.
Growing Profit Margin: A50 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: A50 is unprofitable, and losses have increased over the past 5 years at a rate of 68.8% per year.
Accelerating Growth: Unable to compare A50's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A50 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-9.8%).
Return on Equity
High ROE: A50 has a negative Return on Equity (-11.32%), as it is currently unprofitable.
Next Steps
Financial Health
How is Thomson Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: A50's short term assets (SGD285.8M) exceed its short term liabilities (SGD73.5M).
Long Term Liabilities: A50's short term assets (SGD285.8M) do not cover its long term liabilities (SGD668.0M).
Debt to Equity History and Analysis
Debt Level: A50's debt to equity ratio (117.4%) is considered high.
Reducing Debt: Insufficient data to determine if A50's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A50's debt is not well covered by operating cash flow (8.1%).
Interest Coverage: Insufficient data to determine if A50's interest payments on its debt are well covered by EBIT.
Balance Sheet
Next Steps
Dividend
What is Thomson Medical Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A50's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A50's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A50's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A50's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A50's dividend in 3 years as they are not forecast to pay a notable one for the SG market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.8yrs
Average management tenure
CEO
Chiang Yin Wong (52 yo)
0.92
Tenure
Dr. Chiang Yin Wong has been Executive Director and Group Chief Executive Officer of Thomson Medical Group Limited since February 1, 2020. Dr. Wong serves as an Independent Director of RHT Health Trust Man...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group CEO & Executive Director | 0.92yr | no data | no data | |
| Group CFO & Executive Director | 1.83yrs | no data | no data | |
| Chief Risk Officer & Director of Group Finance | 1.83yrs | no data | no data | |
| Managing Director of RSP Architecture & Design | no data | no data | no data | |
| Managing Director of Squire Mech Mechanical & Electrical Engineering | no data | no data | no data | |
| Managing Director of RSP Civil & Structural Engineering | no data | no data | no data | |
| Group Chief Financial Officer of TMC Life Sciences Berhad | no data | no data | no data | |
| Joint Secretary | 2.33yrs | no data | no data | |
| Joint Secretary | 2.33yrs | no data | no data | |
| Group CEO of TMC Life Sciences Berhad & CEO of Thomson Hospital Kota Damansara | no data | no data | no data | |
| General Manager & COO of Thomson Medical Pte Ltd | 0.17yr | no data | no data |
1.8yrs
Average Tenure
45.5yo
Average Age
Experienced Management: A50's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group CEO & Executive Director | 0.92yr | no data | no data | |
| Group CFO & Executive Director | 1.83yrs | no data | no data | |
| Non-Executive Independent Chairman | 5.08yrs | no data | 0.059% SGD 811.2k | |
| Independent Director | 5yrs | no data | 0.057% SGD 780.0k | |
| Non-Executive Non-Independent Director | 2.75yrs | no data | no data | |
| Non-Executive Non-Independent Director | 1.83yrs | no data | no data | |
| Independent Non-Executive Director | 1.67yrs | no data | no data |
1.8yrs
Average Tenure
60yo
Average Age
Experienced Board: A50's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Thomson Medical Group Limited
- Ticker: A50
- Exchange: SGX
- Founded: 1979
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: S$1.375b
- Shares outstanding: 26.44b
- Website: https://www.thomsonmedicalgroup.com
Number of Employees
Location
- Thomson Medical Group Limited
- 101 Thomson Road, No. 20-04/05
- United Square
- Singapore
- 307591
- Singapore
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| A50 | SGX (Singapore Exchange) | Yes | Ordinary Shares | SG | SGD | Apr 2018 |
| 3H5 | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Apr 2018 |
Biography
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. Th...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/21 11:12 |
| End of Day Share Price | 2021/01/21 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.